Related Experiment Videos
Beta-endorphin does not protect alkylation of opiate receptor by N-ethylmaleimide
Abstract:
Rat brain membranes were incubated in N-ethylmaleimide (NEM, 0.5-1.0 mM) in the presence and absence of various concentrations of morphine, Leuenkephalin and human beta-endorphin (beta h-EP). After sufficient washing, the binding of dihydromorphine (DHM), [D-Ala-D-Leu]-enkephalin (DADLE) and tritiated beta h-EP was 10-40% above that of membranes treated with NEM alone. There was no additive effect of morphine and Leu-enkephalin with respect to their effect on recovery of beta h-EP binding. Evaluation of beta h-EP as protecting ligand proved to be difficult since preincubation completely inhibits subsequent DHM and DADLE binding unless a more extensive washing protocol is employed. A protocol for washing beta h-EP preincubated membranes using a Tris-phosphate buffer of pH 6 containing 150 mM NaCl, 20 mM MgCl2 and 10% glycerol was used to recover enough binding potential to evaluate the effects of beta h-EP preincubation towards NEM treatment. Preincubation with beta h-EP itself at 0.1-1.0 microM did not result in any increased recovery of opiate binding, in contrast to the findings with the other two ligands.
Insights
Morphine and Leu-enkephalin protect rat brain membranes from N-ethylmaleimide (NEM) damage, enhancing opiate receptor binding. However, human beta-endorphin (beta h-EP) did not show this protective effect, even with optimized washing protocols.
Area of Science:
- Neuroscience
- Pharmacology
- Biochemistry
Background:
- Opiate receptors are crucial targets for pain management and other neurological functions.
- N-ethylmaleimide (NEM) is a chemical agent that can modify sulfhydryl groups, potentially affecting receptor binding.
- Understanding how different ligands interact with opiate receptors under chemical stress is important for drug development.
Purpose of the Study:
- To investigate the protective effects of morphine, Leu-enkephalin, and human beta-endorphin (beta h-EP) against N-ethylmaleimide (NEM)-induced damage in rat brain membranes.
- To evaluate the impact of these ligands on the binding of specific radioligands (dihydromorphine, DADLE, and tritiated beta h-EP) after NEM treatment.
- To determine if beta h-EP exhibits protective properties similar to other opiate ligands.
Main Methods:
- Rat brain membranes were incubated with N-ethylmaleimide (NEM) in the presence or absence of varying concentrations of morphine, Leu-enkephalin, and beta h-EP.
- Following incubation and washing, the binding of radiolabeled dihydromorphine (DHM), [D-Ala-D-Leu]-enkephalin (DADLE), and beta h-EP was measured.
- A specialized washing protocol using Tris-phosphate buffer was developed to assess beta h-EP's protective effects.
Main Results:
- Morphine and Leu-enkephalin pre-treatment resulted in 10-40% recovery of opiate binding after NEM treatment compared to NEM alone.
- No additive protective effect was observed when morphine and Leu-enkephalin were combined.
- Human beta-endorphin (beta h-EP) did not demonstrate a protective effect against NEM treatment, even with optimized washing protocols, unlike the other tested ligands.
Conclusions:
- Morphine and Leu-enkephalin can protect opiate binding sites from NEM modification in rat brain membranes.
- Human beta-endorphin (beta h-EP) does not appear to offer similar protection under the tested conditions.
- The findings highlight differential protective mechanisms among opiate receptor ligands against chemical modification.